Trials / Completed
CompletedNCT02907996
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea
A Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Sovaldi in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,033 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to collect and assess data related to safety and effectiveness of Sovaldi treatment regimens, per the approved prescribing information for Sovaldi, in routine clinical practice and report results to Korean Ministry of Food and Drug Safety (MFDS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sofosbuvir | 400 mg tablet administered orally once daily |
Timeline
- Start date
- 2016-09-09
- Primary completion
- 2021-12-09
- Completion
- 2021-12-09
- First posted
- 2016-09-20
- Last updated
- 2021-12-27
Locations
72 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02907996. Inclusion in this directory is not an endorsement.